Interleukin-1α regulates G1 cell cycle progression and arrest in thyroid carcinoma cell lines NIM1 and NPA

被引:14
作者
Zeki, K [1 ]
Morimoto, I
Arao, T
Eto, S
Yamashita, U
机构
[1] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 8078555, Japan
[2] Univ Occupat & Environm Hlth, Sch Med, Dept Immunol, Kitakyushu, Fukuoka 8078555, Japan
关键词
D O I
10.1677/joe.0.1600067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study provides the first report that the same cytokine (interleukin-1 (IL-1)) can induce opposite effects on cyclin-dependent kinases (Cdks) and Cdk inhibitors (Cd-kis) in the G(1) phase even in the same type of cancer cells (papillary thyroid carcinoma cells). Cell cycle analysis revealed an increase in NIM1 cells and a decrease in NPA cells in the S and G(2)+M phases after treatment with IL-1 alpha. The addition of IL-1 alpha to NIM1 cells reduced the expression of p16 and p21 protein and induced the expression of Cdk2 and Cdk4 protein, which leads to the phosphorylation of retinoblastoma protein. The addition of IL-1 alpha to NPA cells induced the expression of p27 protein and reduced the expression of Cdk2 protein, which leads to induction of p107 protein expression. It is of interest that p21 protein expression was not observed in NPA cells. These results suggest that several Cdks and Cdkis play a regulatory role in the G(1) cell cycle progression and arrest induced by IL-1 alpha in thyroid carcinoma cell lines.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 35 条
[1]   INHIBITION OF HUMAN THYROID PEROXIDASE GENE-EXPRESSION BY INTERLEUKIN-1 [J].
ASHIZAWA, K ;
YAMASHITA, S ;
TOBINAGA, T ;
NAGAYAMA, Y ;
KIMURA, H ;
HIRAYU, H ;
IZUMI, M ;
NAGATAKI, S .
ACTA ENDOCRINOLOGICA, 1989, 121 (04) :465-469
[2]  
Blanchard DA, 1997, J IMMUNOL, V158, P3054
[3]  
Calabro V, 1996, INT J CANCER, V67, P29, DOI 10.1002/(SICI)1097-0215(19960703)67:1<29::AID-IJC7>3.0.CO
[4]  
2-1
[5]   P53-DEPENDENT REPRESSION OF CDK4 TRANSLATION IN TGF-BETA-INDUCED G(1) CELL-CYCLE ARREST [J].
EWEN, ME ;
OLIVER, CJ ;
SLUSS, HK ;
MILLER, SJ ;
PEEPER, DS .
GENES & DEVELOPMENT, 1995, 9 (02) :204-217
[6]   HIGH PREVALENCE OF MUTATIONS OF THE P53 GENE IN POORLY DIFFERENTIATED HUMAN THYROID CARCINOMAS [J].
FAGIN, JA ;
MATSUO, K ;
KARMAKAR, A ;
CHEN, DL ;
TANG, SH ;
KOEFFLER, HP .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :179-184
[7]   INACTIVATION OF A CDK2 INHIBITOR DURING INTERLEUKIN 2-INDUCED PROLIFERATION OF HUMAN T-LYMPHOCYTES [J].
FIRPO, EJ ;
KOFF, A ;
SOLOMON, MJ ;
ROBERTS, JM .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) :4889-4901
[8]  
GRIECO D, 1990, J BIOL CHEM, V265, P19343
[9]  
Hirai A, 1997, J BIOL CHEM, V272, P13
[10]   STIMULATORY EFFECT OF INTERLEUKIN-1-ALPHA ON PROLIFERATION THROUGH A CA2+/CALMODULIN-DEPENDENT PATHWAY OF A HUMAN THYROID-CARCINOMA CELL-LINE, NIM-1 [J].
INOKUCHI, N ;
ZEKI, K ;
MORIMOTO, I ;
NAKANO, Y ;
FUJIHIRA, T ;
YAMASHITA, U ;
YANAGIHARA, N ;
IZUMI, F ;
ETO, S .
JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (07) :670-676